Skip to main content
Clinical Trials/EUCTR2017-004669-28-ES
EUCTR2017-004669-28-ES
Active, not recruiting
Phase 1

A clinical tryal of the utility of ozone in patients with implantation failures

CENTRO GINECOLOGICO GINFER0 sites45 target enrollmentOctober 25, 2018

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Evaluate the action of ozone in the regulation, concentration and activation of uterine NK. Quantify the cytokines present in the uterine decidua pre and post ozone exposure in the uterus. Quantify the NK present in the uterine decidua pre and post ozone exposure in the uterus.
Sponsor
CENTRO GINECOLOGICO GINFER
Enrollment
45
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2018
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
CENTRO GINECOLOGICO GINFER

Eligibility Criteria

Inclusion Criteria

  • Patients who come to the reproduction unit who have previously undergone at least one cycle of IVF with their own oocytes or with donation of oocytes without achieving NRV and will make a deferred transfer, either from their own vitrified embryos or from donated embryos.
  • Age between 18 and 40 years
  • BMI (Body Mass Index) \<18 or\> 32 kg / m2
  • Current serologies (performed less than 6 months in advance) with full analysis battery
  • Immunological analysis prior to treatment, quantification of NK in blood, IL\-12, IL\-15 and IL\-18
  • In the previous cycle / years, the patient suffered
  • Repeated implementation failures (at least two transfers or failed transferences)
  • Suspected uterine factor compromised
  • Repeated miscarriages (at least two abortions)
  • Biochemical pregnancies (at least two pregnancy tests between 10\-20 mUI / ml in blood)

Exclusion Criteria

  • genetic diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials